🎗 Think cancer care ends with treatment? Think again. Click to hear how nurses like Dr. Erin Dickman are changing the game for survivors. Erin Dickman, DNP, RN, OCN is Clinical Program Specialist for ImpediMed, and an experienced oncology nurse leader with over 15 years in clinical care, education, and program development. She earned her doctorate from The Ohio State University and is a trained human-centered design practitioner. An expert in evidence-based lymphedema surveillance programs, Dr. Dickman brings an evidence-based, practical approach to improving cancer survivorship and nursing practice. Her innovative work has been highlighted by the American Nurses Association Innovation Lounge. A national speaker and published author, she’s passionate about translating research into practice and advancing cancer care delivery.With a career marked by visionary thinking, interdisciplinary collaboration, and a passion for advancing oncology nursing practice, she continues to influence the field through education, advocacy, and strategic innovation." She is working to close the persistent gaps in cancer survivorship care, particularly during the vulnerable transition from active treatment to long-term follow-up. Oncology nurses are needed to lead the development and implementation of dynamic, individualized survivorship care plans that address both the physical and emotional effects of cancer treatment. A critical focus of her work is on proactive, evidence-based lymphedema surveillance using advanced tools like bioimpedance spectroscopy (BIS), aiming to prevent complications and reduce the long-term financial and quality-of-life burdens patients face. By empowering nurses with the skills and resources to provide comprehensive survivorship support, she advocates for a model of care that is continuous, patient-centered, and rooted in early intervention."If awarded a $1 billion grant, I would revolutionize cancer survivorship care by addressing a critical gap: the lack of consistent, proactive monitoring for long-term side effects like lymphedema. Too often, survivors are without structured follow-up, leaving symptoms unrecognized until they significantly impact quality of life. To close this care gap, I would create a nationwide, nursing-led program focused on early symptom surveillance using advanced technology. Rooted in evidence-based practice and holistic, person-centered care, this initiative would integrate precision medicine and interprofessional collaboration to ensure every survivor receives continuous, meaningful support. My goal is to empower survivors to live well beyond their diagnosis and set a new standard for equitable, long-term oncology care.”This conversation is a must-listen for nurses, healthcare providers, and anyone passionate about improving long-term outcomes for cancer survivors.💡 Key Takeaways:💧 Lymphedema affects 1 in 6 cancer survivors and is often reversible when caught early.🧠 Education and consistent follow-up are key to empowering patients post-treatment.🩺 Nurses are vital in building trust, supporting recovery, and implementing care plans.🔍 Surveillance models allow for earlier interventions and improved patient outcomes.🔁 Survivorship care must be dynamic, personalized, and evidence-based.💡 Innovative tech tools can move lymphedema care from reactive to preventative.Connect with Dr. Erin Dickman on LinkedIn: https://www.linkedin.com/in/erin-dickman/Learn more about the work she is doing as the Clinical Program Specialist at Impedimed: www.impedimed.com Connect with Nurse Rosa: https://linktr.ee/nurserosaspeaks
続きを読む
一部表示
26 分
2025/07/0230 分
42 分
27 分
32 分
49 分
20 分
21 分